New genes emerging for colorectal cancer predisposition

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
• Genetic factors contribute significantly to CRC susceptibility, including Mendelian syndromes (e.g., Lynch syndrome) and complex polygenic inheritance.
• A substantial proportion of CRC cases exhibit familial aggregation without a known germline genetic cause.

Purpose of the Study:

• To identify novel genetic factors contributing to colorectal cancer predisposition.
• To explore the role of advanced sequencing technologies in discovering new CRC susceptibility genes.
• To characterize a newly identified form of genetic CRC predisposition.

Main Methods:

• Utilizing whole-genome sequencing (WGS) to analyze germline DNA.
• Investigating genetic variations associated with colorectal cancer.
• Identifying mutations in specific genes linked to hereditary cancer syndromes.

Main Results:

• Germline mutations in the POLE and POLD1 genes were identified as a cause of CRC genetic predisposition.
• This newly identified genetic predisposition is termed polymerase proofreading-associated polyposis.
• Whole-genome sequencing facilitated the discovery of these disease-predisposing mutations.

Conclusions:

• Mutations in POLE and POLD1 represent a significant genetic cause of colorectal cancer.
• Polymerase proofreading-associated polyposis is a newly recognized hereditary CRC syndrome.
• Advanced sequencing technologies are crucial for uncovering the genetic basis of complex diseases like CRC.